Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

NMDA Receptors Formed by NR1 in Xenopus laevisOocytes Do Not Contain the Endogenous Subunit XenU1

Tim Green, Cheryl A. Rogers, Anis Contractor and Stephen F. Heinemann
Molecular Pharmacology February 2002, 61 (2) 326-333; DOI: https://doi.org/10.1124/mol.61.2.326
Tim Green
Molecular Neurobiology Laboratory, the Salk Institute for Biological Studies, La Jolla, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl A. Rogers
Molecular Neurobiology Laboratory, the Salk Institute for Biological Studies, La Jolla, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anis Contractor
Molecular Neurobiology Laboratory, the Salk Institute for Biological Studies, La Jolla, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen F. Heinemann
Molecular Neurobiology Laboratory, the Salk Institute for Biological Studies, La Jolla, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Activation of N-methyl-d-aspartate-selective ionotropic glutamate receptors (NMDA receptors) requires two agonists, glutamate and glycine. These ligands are thought to bind to the NR2 and NR1 subunits, respectively, apparently ruling out the formation of functional homomeric receptors. However, NMDA-mediated currents are observed when the mammalian NR1 subunit is expressed alone inXenopus laevis oocytes. These currents have been generally ascribed to a functional association between NR1 and the endogenous glutamate receptor subunit XenU1. To determine whether such a functional association does in fact occur, we have isolated cDNAs for both XenU1 and XenU1a, a presumed nonallelic counterpart. We investigated whether the coexpression of either XenU1 or XenU1a with NR1 in either X. laevis oocytes and human embryonic kidney (HEK) 293 cells had any effect on the observed NMDA receptor responses. In oocytes, coinjection of XenU1 with NR1 did not increase the observed currents compared with injection of NR1 alone; similarly, in HEK 293 cells, coexpression of XenU1 and NR1 did not result in the formation of functional channels. We also found no pharmacological or biochemical evidence for interaction between the two subunits. We conclude, therefore, that XenU1 does not associate with the NR1 subunit and that an alternative explanation must be sought for the channels observed when NR1 is expressed alone in oocytes.

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 61 (2)
Molecular Pharmacology
Vol. 61, Issue 2
1 Feb 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
NMDA Receptors Formed by NR1 in Xenopus laevisOocytes Do Not Contain the Endogenous Subunit XenU1
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

NMDA Receptors Formed by NR1 in Xenopus laevisOocytes Do Not Contain the Endogenous Subunit XenU1

Tim Green, Cheryl A. Rogers, Anis Contractor and Stephen F. Heinemann
Molecular Pharmacology February 1, 2002, 61 (2) 326-333; DOI: https://doi.org/10.1124/mol.61.2.326

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

NMDA Receptors Formed by NR1 in Xenopus laevisOocytes Do Not Contain the Endogenous Subunit XenU1

Tim Green, Cheryl A. Rogers, Anis Contractor and Stephen F. Heinemann
Molecular Pharmacology February 1, 2002, 61 (2) 326-333; DOI: https://doi.org/10.1124/mol.61.2.326
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
  • Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics